TP53 and urinary bladder cancer: They conclude After 10 years of research, evidence is not sufficient to conclude whether changes in P53 act as markers of outcome in patients with bladder cancer’ and state That a decade of research on P53 and bladder cancer has not placed us in a better position to draw conclusions relevant to the clinical management of patients is frustrating.